secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKWELL MEDICAL, INC. (RMTI)
CIK:        0001041024
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001628280-26-031629
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rockwell Medical Q1 net sales $17.3M (-8% YoY); guides FY26 gross margin 18-22%
-------------------------------------------------------------------------------

- Net sales $17.3M, down 8% from $18.9M; net loss $1.6M vs $1.5M in prior year.
- Gross margin improved to 17% from 16%; gross profit $2.9M flat YoY.
- FY26 guidance: net sales $70-75M, gross margin 18-22%, Adj. EBITDA $1-2M, positive op. cash flow.
- Operational changes expected to generate >$3M annualized additional gross profit.
- Cash $23.9M at March 31; final $0.5M Evoqua earnout payment made in April.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1041024/000162828026031629/0001628280-26-031629-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1041024/000162828026031629/rmti-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-031629

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer